HAC: ACP (IM Ess.) Flashcards
Listeria monocytogenes: gram stain
gram + rods
L. monocytogenes meningitis tx
ampicillin
Common groups infected w/L. monocytogenes meningitis
- elderly
- neonates
- immunocompromised
Most sensitive/specific test for HSV encephalitis
Cerebrospinal fluid polymerase chain reaction assay is the most sensitive and specific test for the diagnosis of herpes simplex encephalitis.
S. pneumo: gram stain
gram + diplococci
S. pneumo meningitis empiric therapy
-vanc + 3rd gen. ceph (e.g. ceftriaxone)
Imaging in suspicion of stroke
- Non-contrast CT Head ==> r/o hemorrhagic stroke
2. MRI if CT negative
Important medication in resolving acute ischemic stroke
-aspirin vs. clopidogrel
Guidelines for thrombolysis in ischemic stroke
- rTPA treatment be initiated within 1 hour of arrival at the emergency department and within 3 hours of symptom onset
- benefit of rtPA up to 4.5 hours after stroke onset w/ exclusion criteria = age greater than 80 years, severe stroke, diabetes mellitus with a previous infarct, and any anticoagulant use
Dx testing suspected subarachnoid hemorrhage
- CT w/out contrast
- if neg. ==> lumbar puncture
- RBCs or xanthochromia indicate signs of SAH
Criteria for hospitalization after TIA
-ABCD2 score: Age of 60 years or greater (+1) Blood pressure of >140/90 (+1) Clinical sx: hemiparesis (+2) Duration of >60 min. (+2) Diabetes mellitus (+1) -Score 3 or higher ==> indication for hospitalization
Treatment of blood pressure in ischemic stroke
Patients with ischemic stroke who are ineligible to receive recombinant tissue plasminogen activator and have no evidence of end-organ damage should not be treated for elevated blood pressure of up to 220/120 mm Hg.
Incidental lung nodules f/u
- never smoked: 8mm ==> biopsy vs. 3,9,24 mo. CT f/u
- never smoked: no f/u
- current/former smokers: CT @ 12mo.
- solid nodule stable on CT x 2 yrs = benign ==> no further f/u
Lung cancer tx
- early-stage (stages I and II) disease ==> surgery
- IB (>3cm tumor) ==> + adj. chemo
- Chemotherapy plus radiation is indicated for locally advanced tumors (i.e., stage III disease characterized by mediastinal lymph node involvement)
Small cell lung cancer treatment
- surgery = early stage
- chemo + radiation = “limited stage” (limited to chest)
- chemo only = extensive stage
Evaluation of breast mass
“Triple assessment”:
- palpation
- mammography +/- US
- FNA/biopsy
F/U for breast mass
- simple cyst ==> f/u exam 4-6 wks after aspiration for recurrence/residual lump
- solid mass ==> FNAB or excisional biopsy; if neg. ==> close clinical f.u.
Exceptions to typical colon cancer screening
-early colonoscopy for any individual w/first deg. family member w/colon cancer
Stage III colon cancer tx
- resection
2. adjuvant chemo
Method of estimating GFR
- equation-based calculation of GFR
- CKD-EPI (CKD epidemiology collaboration)
- Cr clearance overestimates GFR (because some is excreted), but approximates true GFR in patients w/out kidney disease
Histology in rapidly-progressing glomerulonephritis
-most commonly crescentic glomerulonephritis
glomerulonephritis characteristics
-nephritic syndrome
- ==> hematuria, oliguria, HTN, acute kidney failure
- ==> pyuria, hematuria, cellular/granular casts
+/- proteinuria
Examples of nephrotic syndromes
-MCD
-FSGS
-membranous glomerulonephropathy
==> edema, hypoalbuminemia, proteinuria, bland sediement (no casts, RBCs, leuks)
MCD disease type
nephrotic syndrome
FSGS disease type
nephrotic syndrome
Membranous disease type
nephrotic syndrome
Dysmorphic erythrocytes or acanthocytes on urine micro ==>
- glomerular hematuria
- indication of glomerulonephritis
Evaluation/work-up with glomerular hematuria
- urine protein-cr ratio/serum cr measurement
- serum complement
- hepatitis panel
- blood cx
- ANA, ANCA, anti-GBM, antistreptolysin
Evaluations of hematuria
repeat UA
>40yo ==> lower/upper urinary tract workup
Evaluation of sustained, isolated proteinuria
- split urine collection ==> r/o orthostatic proteinuria
2. imaging vs. kidney biopsy
Tx of rhabdomyolysis
rapid NS
Lab findings in rhabdo
- serum CK > 5000
- blood on urine dip w/out sig. hematuria (myoglobin from m. breakdown)
- ==> hypocalcemia, hyperphosphatemia, hyperkalemia, hyperuricemia, metablic acidosis
- AK
Serum osmolality concentration
serum osm = 2[Na] + [BUN]/2.8 + [glucose]/18
Types/categories of hypo-osmolol hyponatremia
- hypovolemic
- euvolemic
- hypervolemic
Causes of hyperosmolal hyponatremia
- extreme hyperglycemia
- exogenously administered solutes: mannitol or sucrose
Cuases of isosmotic hyponatremia
- glycine
- sorbitol
- pseudohyponatremia (lab artifact w/hyperglobulinemia or severe hyperlipidemia)
Tx of symptomatic hyponatremia 2/2 SIADH
- 3% (hypertonic) saline
- NS ==> excretion of most of infused sodium and retention of water ==> positive water balance
Causes of SIADH
- antidepressants
- xx
Tx of significant hypernatremia
correct water deficit w/5% dextrose
Potential causes of nephrogenic diabetes insipidus
- medications (for example, lithium)
- hypokalemia
- hypercalcemia
- sickle cell disease and trait
- amyloidosis
Tx of nephrogenic DI
- adequate water intake
- salt restriction
- thiazide diuretic
Sodium polystyrene use/characteristics
- cation exchange resin
- removes K from body ==> use in long-term control of hyperkalemia
- slow onset; not useful in acute setting
- contraindicated in pt.s w/recent bowel surgery
Characteristics of refeeding sydnrome
-occurs during reintro of nutrition after period of (relative) starvation
==> hypophosphatemia, hypokalemia, and hypomagnesemia
Tx of hypoparathyroidism
calcium
Tx of acute hypercalcemia
normalization of intravascular volume with saline will improve delivery of calcium to the renal tubule and aid in excretion of calcium.
Urine anion gap (UAG)
Urine anion gap (UAG) = ([urine sodium] + [urine potassium]) – [urine chloride]
Normal = 30-50
Type 2 RTA characteristics
-Type 2 (proximal) RTA = defect in regenerating bicarbonate in the proximal tubule
-normal anion gap metabolic acidosis
-hypokalemia
glycosuria (w/normal plasma glucose)
-low-molecular-weight proteinuria
-kidney phosphate wasting
-urine pH is less than 5.5
-no nephrocalcinosis/nephroliths
Type 1 RTA characteristics
- Hypokalemic distal (type 1) renal tubular acidosis
- normal anion gap metabolic acidosis
- hypokalemia
- urine pH > 6.0
- nephrocalcinosis
- *no ability to excrete H+ ions
Possible causes of type 1 RTA
- autoimmune: Sjögren syndrome, systemic lupus erythematosus, or rheumatoid arthritis
- drugs: lithium or amphotericin B
- hypercalciuria
- hyperglobulinemia
Expected compensation in respiratory alkalosis
PCO2 decrease by 10 ==> HCO3 decrease by 2
Expected compensation in respiratory acidosis
- *predicted increase in the serum bicarbonate level is calculated as 1 mEq/L (1 mmol/L) for each 10 mm Hg (1.3 kPa) increase in Pco2 (acute)
- *4 mEq/L (4 mmol/L) for each 10 mm Hg (1.3 kPa) increase in Pco2 (chronic).
Evaluation of metabolic alkalosis
- clinical assessment of volume status and blood pressure; hypovolemic = “saline-responsive”
- measurement of urine sodium and chloride levels can help distinguish the various causes.
Urine chloride use in evaluation of metabolic alkalosis
- low urine chloride levels ( vomiting vs. decreased effective arterial blood (diuretics or low cardiac output)
- high urine chloride levels (>15 mEq/L [15 mmol/L]) ==> diuretics vs. (rare) genetic tubular disorder (Bartter syndrome or Gitelman syndrome)
Compensation in metabolic acidosis
Winter’s formula:
Expected Pco2 = (1.5 × [HCO3] + 8) ± 2 = 26 ± 2
Calculation of corrected bicarbonate in AG metabolic acidosis
- Corrected [HCO3] = measured [HCO3] + (measured anion gap – 12)
- if corrected serum bircarb deviates from expected then there is another metabolic process in play
Correction in metabolic alkalosis
Pco2 would be expected to increase by 0.7 mm Hg (0.09 kPa) for each 1 mEq/L (1 mmol/L) increase in the serum bicarbonate level
FENa use
- distinguish source of AKI
- prerenal vs. infrarenal vs. postrenal
- xx
Evaluation of AKI
- Kidney imaging, typically US, considered in all patients w/ AKI esp. w/ risk factors for obstruction are present
- FENa can be useful, but is variable in obstruction
Tx for acute pericarditis
- NSAIDs/antiinflamatory meds + observation/supportive ==> most cases resolve w/in 24 hours
- steroids only if other anti-inflam contraindicated or refractory cases (==> increase risk recurrence)
Tx of pituitary apoplexy
- glucocorticoids
2. neurosurgery/tumor removal
Thyroid d/o w/low RAIU
- subacute/lymphocytic thyroiditis ==>
1. hyperthyroid x weeks
2. hypothyroid x weeks
3. euthyroid
TSH goal in hypothyroidism
0.1 - 2.5
Hypothyroid in preg.
- levothyroxine dose need increases by 30-50%
- test/increase dose in first semester followed by repeat testing in 2-4 weeks
Testing in incidental adenoma
Nearly 10% of adrenal incidentalomas are functional, and testing is usually necessary to identify functional tumors secreting catecholamines, cortisol, or aldosterone.
Screening in T1DM
- lipid panel @ puberty
- urine albumin-creatinine ratio @ 10yo+ AND dx of DM1 for 5 or more years
- dilated funduscopic examination @ 10 years of age or older AND dx with type 1 diabetes for 3 to 5 years.
Dx of DM
-A1c > 6.5
-Fasting Gluc > 120
If results of two different diagnostic tests for diabetes mellitus are discordant, the test that is diagnostic of diabetes should be repeated.
Modifiable risk factors for osteoporosis
- adequate amounts of both calcium and vitamin D
- regular exercise
- cessation of cigarette smoking
- avoidance of alcohol abuse
Contraindication to oral bisphosphonates and alternative therapies
-GERD
==> IV bisphosphonates (zoledronic acid)
Who should receive osteoporosis therapy?
- dx of osteo via DEXA/fragility fx OR
- (FRAX) risk of major osteoporotic fracture over the next 10 years is 20% OR
- risk of hip fracture over the next 10 years is 3% or greater
Outpatient vs. Inpatient management of diverticulitis
- most ==> outpatient + oral abx (metro + cipro
- hospitalization/IV abx are generally reserved for patients with evidence of peritonitis, those with significant comorbidities, or those who cannot tolerate oral intake.
Indications of upper endoscopy in dyspepsia
-symptom onset after age 50 years
-anemia
-dysphagia
-odynophagia
-vomiting
-weight loss
-fhx of upper gastrointestinal malignancy
personal history of peptic ulcer disease, gastric surgery, or gastrointestinal malignancy
-abdominal mass or lymphadenopathy on exam
Characteristics of gilbert syndrome
Gilbert syndrome is a common and frequently incidentally discovered cause of indirect (unconjugated) hyperbilirubinemia that usually does not require evaluation or treatment.
Acute viral hepatitis presentation
- elevations of liver aminotransferase levels
- increased direct hyperbilirubinemia
Elevated alk phos ==>
cholestatic pattern of liver injury
Primary biliary cirrhosis presentation
- PBC = immune-mediated cause of chronic liver inflammation
- elevated serum alkaline phosphatase and bilirubin levels disproportionately higher than the aminotransferase elevation
Hep C therapy
- peginterferon + ribavirin
- addition of an NS3/4A protease inhibitor for patients with genotype 1 hepatitis C virus.
Management of chronic hep B
- as long as no elevation in LFTs ==> monitor
- serial LFTs q3-6mo.
Immune-tolerant hep B
- immune-tolerant, identified by the presence of a circulating viral level in the absence of markers of liver inflammation
- typically occurs in patients born in hepatitis B–endemic areas such as Southeast Asia or Africa in whom HBV was likely acquired perinatally
Dx of SBP
In patients with cirrhosis and ascites, an ascitic fluid neutrophil count of ≥250/µL (250 × 106/L) is diagnostic for spontaneous bacterial peritonitis.